Zhitong Finance App News, Huahai Pharmaceutical (600521.SH) issued an announcement. The company recently received the “Drug Registration Certificate” for ferrous succinate tablets approved and issued by the State Drug Administration. Ferrous succinate tablets are used for the prevention and treatment of iron deficiency anemia. The drug is approved for production according to Class 3 chemicals and can be considered to have passed the consistency evaluation. The approval of this product further enriches the company's product line and helps enhance the market competitiveness of the company's products.

Zhitong Finance App News, Huahai Pharmaceutical (600521.SH) issued an announcement. The company recently received the “Drug Registration Certificate” for ferrous succinate tablets approved and issued by the State Drug Administration. Ferrous succinate tablets are used for the prevention and treatment of iron deficiency anemia. The drug is approved for production according to Class 3 chemicals and can be considered to have passed the consistency evaluation. The approval of this product further enriches the company's product line and helps enhance the market competitiveness of the company's products.